"Dimethylamphetamine"

-dimethoxyamphetamine, 2,5-dimethoxy-4-ethylamphetamine, 4-methyl-2,5-dimethoxyamphetamine, levamphetamine, 3,4-methylenedioxy-amphetamine, 3,4-methylenedioxymethamphetamine, methamphetamine, methamphetamine racemate, 5-methoxy-3,4-methylenedioxyamphetamine, N-ethylamphetamine, 3,4-methylenedioxy-N-ethylamphetamine, N-hydroxy-3,4-methylenedioxyamphetamine, N,N-dimethylamphetamine, 4-methoxyamphetamine, 3,4,5

analogs that differ only in the number of methyl substituents on the terminal amine group. Starting with 3,4-methylenedioxy-N-methylamphetamine, 3,4-methylenedioxy-N,N-dimethylamphetamine (MDDMA) and 3,4-methylenedioxy-N,N,N-trimethylamphetamine (MDTMA) were prepared. We evaluated the functional activities of the compounds at all three monoamine transporters in native brain tissue and cells expressing

: * * Aminoxaphen - Aminorex * * Cathinone * * Fenethylline * * Methcathinone * * Mephedrone * * Methylaminorex * * Amphetamine variants (eg, 3,4-methylenedioxymethamphetamine [MDMA], N -ethylamphetamine, N,N -dimethylamphetamine) Schedule IIThese substances have a high abuse potential with severe psychic or physical dependence liability. Schedule II controlled

: * * Aminoxaphen - Aminorex * * Cathinone * * Fenethylline * * Methcathinone * * Mephedrone * * Methylaminorex * * Amphetamine variants (eg, 3,4-methylenedioxymethamphetamine [MDMA], N -ethylamphetamine, N,N -dimethylamphetamine) Schedule IIThese substances have a high abuse potential with severe psychic or physical dependence liability. Schedule II controlled

: * * Aminoxaphen - Aminorex * * Cathinone * * Fenethylline * * Methcathinone * * Mephedrone * * Methylaminorex * * Amphetamine variants (eg, 3,4-methylenedioxymethamphetamine [MDMA], N -ethylamphetamine, N,N -dimethylamphetamine) Schedule IIThese substances have a high abuse potential with severe psychic or physical dependence liability. Schedule II controlled

: * * Aminoxaphen - Aminorex * * Cathinone * * Fenethylline * * Methcathinone * * Mephedrone * * Methylaminorex * * Amphetamine variants (eg, 3,4-methylenedioxymethamphetamine [MDMA], N -ethylamphetamine, N,N -dimethylamphetamine) Schedule IIThese substances have a high abuse potential with severe psychic or physical dependence liability. Schedule II controlled

* Dimethylamphetamine * Dobutamine * DOPA (Dextrodopa, Levodopa) * Dopamine * Dopexamine